Social Capital Suvretta Holdings Corp. III

If you purchased Social Capital Suvretta Holdings Corp. III securities and would like to join the action, please click "Join This Action" below.

SOCIAL CAPITAL (DNAC) STOCK INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE MERGER OF SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – DNAC

January 19, 2022.

New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Social Capital Suvretta Holdings Corp. III (NASDAQ: DNAC) and ProKidney LP is fair to Social Capital shareholders.

The investigation concerns whether Social Capital and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Social Capital shareholders; and (2) disclose all material information necessary for Social Capital shareholders to adequately assess and value the merger consideration. On behalf of Social Capital shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Scroll to Top